| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |